Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
Conditions
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Non Hodgkin's Lymphoma
- Hodgkin's Disease
- Myelodysplastic Syndrome
- Multiple Myeloma
Interventions
- BIOLOGICAL: infusion of allogeneic CIK cells
Sponsor
Singapore General Hospital
Collaborators